Litcius/Paper detail

Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative

Payam Sasanejad, Leila Afshar Hezarkhani, Shahram Arsang‐Jang, Georgios Tsivgoulis, Abdoreza Ghoreishi, Kristian Barlinn, Jan Rahmig, Mehdi Farhoudi, Elyar Sadeghi‐Hokmabadi, Afshin Borhani‐Haghighi, Payam Sariaslani, Athena Sharifi‐Razavi, Kavian Ghandehari, Alireza Khosravi, Craig J. Smith, Yongchai Nilanont, Yama Akbari, Thanh N. Nguyen, Anna Bersano, Nawaf Yassi, Takeshi Yoshimoto, Simona Lattanzi, Animesh Gupta, Ramin Zand, Shahram Rafie, Seyede Pourandokht Mousavian, Mohammad Reza Shahsavaripour, Shahram Amini, Saltanat Kamenova, Аida Kondybayeva, Murat Zhanuzakov, Elizabeth Macri, Christa O’Hana S. Nobleza, Sean Ruland, Anna M. Cervantes‐Arslanian, Masoom Desai, Annemarei Ranta, Amir Moghadam Ahmadi, Mahtab Rostamihosseinkhani, Razieh Foroughi, Etrat Hooshmandi, Fahimeh Haji Akhoundi, Ashfaq Shuaib, David S. Liebeskind, James E. Siegler, José G. Romano, Stephan A. Mayer, Reza Bavarsad Shahripour, Babak Zamani, Amadene Woolsey, Yasaman Fazli, Mojtaba Khazaei, Christian F. Isaac, José Biller, Mario Di Napoli, Mahmoud Reza Azarpazhooh

2021Journal of Stroke and Cerebrovascular Diseases21 citationsDOIOpen Access PDF

Topics & Concepts

MedicineStroke (engine)Internal medicineModified Rankin ScaleTissue plasminogen activatorConfoundingOdds ratioThrombolysisCoronavirus disease 2019 (COVID-19)Emergency medicineIschemic strokeMyocardial infarctionIschemiaDiseaseMechanical engineeringEngineeringInfectious disease (medical specialty)Long-Term Effects of COVID-19COVID-19 and healthcare impactsCOVID-19 Clinical Research Studies